12 February 2025
AgTech startup CroBio raises €850k to reshape agriculture through enhanced microbes
Cheshire-based CroBio, an AgTech startup on a mission to reshape the future of agriculture by harnessing the power of enhanced microbes, announced €805k in new funding to enhance their living soil amendment, a technology designed to improve nutrient retention, water retention...

21 January 2025
Monument Therapeutics announces grant of Chinese patent in support of its MT1988 cognitive impairment associated with schizophrenia program.
Manchester, UK, 21 January 2025 - Monument Therapeutics, a stratified medicine company developing novel treatments for areas of high unmet need in psychiatry and neurology, today announced that the China National Intellectual Property Administration (“CNIPA”) has granted Chinese...

14 January 2025
Monument Therapeutics announces grant of Japanese patent in support of its MT1988 cognitive impairment associated with schizophrenia program
Manchester, UK, 14 January 2025 - Monument Therapeutics, a stratified medicine company developing novel treatments for areas of high unmet need in psychiatry and neurology, today announced that the Japan Patent Office (“JPO”) has granted Japanese patent 7570345, in support of...

13 January 2025
Boehringer Ingelheim acquires fourth license for the development of novel antibody based cancer treatments from Oxford BioTherapeutics
Oxford, UK and San Jose, California, 9 January 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based therapies, today announced that Boehringer Ingelheim has exercised an option for...

7 January 2025
Maxwellia announces strategic leadership appointments to propel future growth
Alderley Park, Cheshire, UK – Monday 6 January 2025 – Maxwellia, the female founded pioneering consumer healthcare company, is pleased to announce two significant additions to its leadership team. Candice Brett has been appointed as Chief Financial Officer (CFO), and Colin...